Search

everythinglearnresearchcommunity

for

Search:↓

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Oral prednisolone helps hair regrowth in alopecia areata.

Mild exercise reduces pain in older rats through a brain chemical, while intense exercise reduces pain in all rats through a different pain-blocking process.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Clascoterone is safe for the heart, even at high doses.

Oxymetazoline cream 1.0% effectively reduces rosacea redness, and using baseline photos improves assessment accuracy.

Baricitinib helps with early hair regrowth in people with alopecia areata.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

The drug combination was safe and showed promise in treating advanced tumors.

The dietary supplement AGA-P improves the effectiveness of hair loss treatments.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

The authors agree that standardizing how PRP methods are reported could help compare results, but note that the link between PRP's contents and hair growth is unclear, and recommend avoiding split-scalp designs in future trials.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.